Corcym S.r.l
10
2
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
30.0%
3 terminated/withdrawn out of 10 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
67%
2 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve
Role: lead
Sorin Universal REgistry on Aortic Valve Replacement
Role: lead
Clinical Investigation of the Freedom SOLO Stentless Heart Valve
Role: lead
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting
Role: lead
Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark
Role: lead
Behavior of Valve Leaflets Following Aortic Valve Implant
Role: lead
PERCEVAL S Valve Clinical Study for Chinese Registration
Role: lead
Clinical Data Collection on Perceval S Sutureless Prosthetic Aortic Valve in the Chinese Population
Role: lead
Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement
Role: lead
PERCEVAL Pivotal Trial
Role: lead
All 10 trials loaded